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Introduction
Cilia are tubulin-based extensions, which can be motile or 
immotile. Immotile cilia, also known as primary cilia, exist as 
monocilia emanating from most vertebrate cells upon entry 
into G0 (1). They possess sensory functions and serve as an 
important hub for signaling processes such as the Hedgehog 
(Hh) pathway (2). Activity of such signaling pathways is crucial 
during development (2) and is also needed for heart formation 
(3, 4). Motile cilia, on the other hand, are typically found in 
multitudes, for instance on cells lining the surface of trachea, 
oviduct, and brain ventricles, and mainly serve to move fluids 
(1). A particular subset of motile cilia are monocilia within the 
left-right organizer (LRO), a transient organ of laterality — the 
node in mice or the Kupffer’s vesicle (KV) in zebrafish. These 
LRO cilia beat in a coordinated fashion and generate a counter- 
clockwise fluid flow that is translated into a biochemical signal. 
It provides the basis for the establishment of left-right (L-R) 
asymmetry and thus the correct placement of visceral organs, 
known as situs solitus (5). Because of the different kinds of 
cilia as well as their divergent functions in tissues and organs, 
ciliopathies are a heterogeneous group of diseases. Interesting-
ly, though, situs anomalies such as those that occur in hetero-
taxy are a feature shared by many ciliopathies (6). Heterotaxy is 
recognized as a cause for heart malformations and consequently 
congenital heart disease (CHD) (7). This has recently been 
corroborated in an ENU-screening approach that revealed that 
mutations in genes affecting the generation and function of 
cilia lead to CHD (8).
We and others previously found that the mechanistic mTOR 
pathway is involved in the establishment of L-R asymmetry (9–
11). When the mTOR pathway is deregulated, nodal cilia length 
is altered and symmetry breaking is not established properly (9, 
11). Biogenesis of mitochondria via PGC1A is one of the many 
processes regulated by the mTOR pathway (12). Furthermore, 
mitochondria are often spatially located proximal to the base of 
cilia, e.g. as observed in photoreceptors, tracheal epithelium of 
vertebrates, or ciliates such as Tetrahymena thermophila (13–15). 
Together, these factors prompted us to investigate whether 
mitochondria influence the formation of cilia and consequently 
cilia-dependent processes such as L-R asymmetry development.
About 1% of all newborns are affected by congenital heart disease (CHD). Recent findings identify aberrantly functioning cilia 
as a possible source for CHD. Faulty cilia also prevent the development of proper left-right asymmetry and cause heterotaxy, 
the incorrect placement of visceral organs. Intriguingly, signaling cascades such as mTOR that influence mitochondrial 
biogenesis also affect ciliogenesis, and can cause heterotaxy-like phenotypes in zebrafish. Here, we identify levels of 
mitochondrial function as a determinant for ciliogenesis and a cause for heterotaxy. We detected reduced mitochondrial 
DNA content in biopsies of heterotaxy patients. Manipulation of mitochondrial function revealed a reciprocal influence on 
ciliogenesis and affected cilia-dependent processes in zebrafish, human fibroblasts and Tetrahymena thermophila. Exome 
analysis of heterotaxy patients revealed an increased burden of rare damaging variants in mitochondria-associated genes 
as compared with 1000 Genome controls. Knock down of such candidate genes caused cilia elongation and ciliopathy-like 
phenotypes in zebrafish, which could not be rescued by RNA encoding damaging rare variants identified in heterotaxy 
patients. Our findings suggest that ciliogenesis is coupled to the abundance and function of mitochondria. Our data further 
reveal disturbed mitochondrial function as an underlying cause for heterotaxy-linked CHD and provide a mechanism for 
unexplained phenotypes of mitochondrial disease.
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natively, we performed KV-specific overexpression of murine 
Pgc1a. Both approaches reduced cilia length in the KV, with the 
pharmacological intervention also reducing the number of cilia 
per KV (Figure 2, A–D). DCHC treatment during somitogenesis 
led to the same defects as treatment during gastrulation stages 
(Supplemental Figure 4). In contrast, inhibition of respiration via 
rotenone treatment or knock down (KD) of Cox5aa did not change 
the number of cilia per KV, yet resulted in elongated KV cilia (Fig-
ure 2, E–H). Manipulation of mitochondria thus inversely affects 
the length of motile cilia in the KV. Length changes of nodal cilia 
can affect ciliary beating and also the establishment of appropri-
ate fluid flow in the KV, which ultimately triggers aberrant symme-
try breaking (9–11, 20–24). We therefore analyzed ciliary beating 
and flow patterns in the KV of zebrafish embryos (Figure 2, I–M). 
Determination of the ciliary beat frequency (CBF) revealed no 
significant changes in DCHC-treated embryos, only a tendency 
toward a slightly increased CBF (Figure 2L). Rotenone treatment, 
however, reduced CBF significantly (Figure 2M). Unexpectedly, 
in the light of shorter cilia, an increased flow velocity could be 
detected in the anterior area of the KV in DCHC-treated embryos 
and in the left KV area for DCHC and rotenone, suggesting a dis-
turbed flow pattern in this area (Figure 2, I–K). The left side of 
the KV is particularly important for symmetry breaking, which 
colocalizes with the downregulation of dand5 mRNA (previously 
known as charon, a negative regulator of the nodal cascade [ref. 
25]) specifically at the left edge of the KV (21, 23). Consistent with 
the dampening of CBF and changes in nodal flow, we observed an 
increased frequency of embryos with aberrant dand5 expression, 
when treated with DCHC or rotenone (Figure 2N). We conclude 
that altered mitochondrial function affects nodal cilia length and 
beating, which as a consequence disturbs fluid flow in the KV and 
early steps in symmetry breaking such as spatial expression of 
dand5. To test whether this is also true for other motile cilia, we 
turned to another model system. The ciliate Tetrahymena thermo-
phila requires functioning motile cilia for a number of processes, 
including swimming or phagocytosis. Rotenone and DCHC treat-
ment affected both processes in Tetrahymena (Supplemental Fig-
ure 5). Similar to the increased flow speed in the KV and potentially 
due to increased ATP availability, DCHC treatment increased 
both the number of moving cells as well as speed of swimming, 
while rotenone treatment reduced both these parameters. Perhaps 
this reflects cilia movement in the KV of zebrafish embryos treated 
with these substances (Figure 2, L and M). We conclude that for-
mation and function of motile cilia depends on mitochondrial 
homeostasis and that this connection is conserved.
Nonmotile primary cilia, however, are also involved in the 
process of symmetry breaking. These cilia lining the KV are 
thought to sense the flow and translate it into leftward gene 
expression (26, 27). Therefore, we analyzed whether immotile 
cilia such as primary cilia generation is also sensitive to altered 
mitochondrial function. We manipulated mitochondria in human 
fibroblasts with the same compounds as in zebrafish (Figure 3, 
A–H, and Supplemental Figure 6). Change of mitochondrial func-
tion in any direction did not impact the number of ciliated cells 
(Figure 3, C and D). However, DCHC treatment reduced cilia 
length, whereas rotenone caused an elongation of primary cilia, as 
we have observed with motile LRO cilia (Figure 3, E and F). Length 
Results
We wondered whether mitochondria could be found spatially 
proximal to the base of nonmotile primary cilia as it has been 
observed for motile cilia or photoreceptors (13–15). We therefore 
analyzed human fibroblasts via cryo-electron tomography, which 
revealed similar colocalization of mitochondria and ciliary base 
(Supplemental Video 1; supplemental material available online 
with this article; https://doi.org/10.1172/JCI98890DS1). More-
over, we found that microtubules project from the mother centri-
ole at the cilium base toward mitochondria, suggesting a commu-
nication between the 2 organelles (Supplemental Video 1).
We then assessed the content of mitochondrial DNA (mtDNA) 
in samples of a heterogeneous cohort of heterotaxy patients. We 
detected a marked decrease of mtDNA levels in these patient 
samples as compared with healthy subjects (Figure 1A and Supple-
mental Figure 1). Yet samples derived from patients suffering from 
other isolated CHDs without visceral situs anomalies or additional 
cilia dysfunction phenotypes showed mtDNA levels compara-
ble to healthy subjects (Figure 1A and Supplemental Table 1). 
This suggests reduced abundance of mitochondria specifically 
in hetero taxy patients. We therefore sought to functionally assess 
the influence of mitochondria on asymmetry development. 
To this end, we pretreated developing zebrafish embryos with 
the isoflavone 3-(2,4-dichlorophenyl)-7-hydroxy-4H-chromen-
4-one (DCHC) to boost mitochondrial biogenesis (16) and gen-
erate elevated mitochondrial levels during developmental stages 
when cilia are involved in symmetry breaking (outlined in Fig-
ure 1B). Alternatively, we used rotenone to inhibit mitochondrial 
respiration during these developmental stages (Figure 1B). For 
both approaches we verified the efficiency of the treatment 
(Supplemental Figure 2). Enhancement as well as reduction of 
mitochondrial function caused phenotypes such as pericardial 
edema and curved tail, which can also be observed in zebrafish 
models of cilia dysfunction (Figure 1, C–E). Furthermore, we 
detected situs anomalies resembling heterotaxy after both treat-
ments when we analyzed heart looping (Figure 1, F and G) and 
pancreas placement (Supplemental Figure 3). Spatially restricted 
expression of leftward genes such as southpaw (spaw) precedes 
heart looping and organ placement (17). We therefore examined 
spaw expression in zebrafish embryos after DCHC or rotenone 
treatment and observed increased occurrence of spatially aber-
rant expression (Figure 1, H and I). To verify this finding, we also 
injected zebrafish embryos with either capped RNA encoding 
murine Pgc1a to induce mitochondria biogenesis or a previous-
ly described translation-blocking morpholino (MO) targeting 
Cox5aa (18) to reduce mitochondrial respiration. Both treatments 
phenocopied the drug treatments with respect to disturbed heart 
looping and pancreas placement (Figure 1G and Supplemental 
Figure 3) and spatially aberrant spaw expression (Figure 1I). We 
thus conclude that mitochondrial homeostasis is important for 
correct situs development in zebrafish.
LRO cilia are instrumental for proper establishment of L-R 
asymmetry (19). We hence visualized cilia in the KV, the LRO of 
zebrafish, after manipulation of mitochondria. We boosted mito-
chondria by treatment with DCHC before the KV formed so that 
at the onset of KV formation and cilium formation mitochondrial 
function was elevated (Supplemental Figure 2, B and C). Alter-
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To further test the influence of mitochondria on ciliogenesis, 
we analyzed primary cilia on cells derived from patients carrying 
biallelic pathogenic variants of MPV17 and NFU1, respectively, 
which cause mitochondrial DNA depletion syndrome 6 (phe-
notype MIM 256810) and multiple mitochondrial dysfunctions 
syndrome (phenotype MIM 605711), respectively (Figure 3, I and 
J) (28, 29). Both patient-derived cell lines showed longer cilia as 
changes of primary cilia also affect their function. To assess this, 
we measured the ability of cells to induce Hh signaling upon stim-
ulation with Smoothened agonist (SAG) after the cells have been 
pretreated with either DCHC or rotenone. Both pretreatments 
triggered reduced capacity for Hh signaling induction (Figure 3, 
G and H). This indicates that the functionality of primary cilia is 
reduced in cells with a state of altered mitochondrial function.
Figure 1. Mitochondrial content and function are associated with heterotaxy and laterality defects. (A) Blood samples from heterotaxy patients  
(n = 69) contain less mtDNA than healthy controls (n = 78) or samples from patients without heterotaxy-spectrum CHDs (n = 20). Kruskal-Wallis test 
with Dunn’s multiple comparison; ****P < 0.0001 for both comparisons. (B) Pharmacological manipulation of zebrafish embryos to stimulate (DCHC)  
or inhibit (rotenone) mitochondrial function. (C) Representative images of DCHC- and control-treated embryos 52 hpf. Arrow indicates pericardial edema. 
Scale bar: 200 µm. (D) Altered mitochondrial function induces pericardial edema. Unpaired, 2-tailed Welch’s t test; DMSO versus rotenone (rot),  
N = 8, n = 184/184, *P = 0.0059; DMSO versus DCHC, N = 5, n = 157/162, **P = 0.0037. (E) Altered mitochondrial function induces curved tail. Two-tailed 
Mann-Whitney test; DMSO versus rotenone, N = 6, n = 141/157, *P = 0.0043; DMSO versus DCHC, N = 4, n = 137/143, **P = 0.0286. (F, G) Detection of 
cml2c mRNA in 52 hpf zebrafish embryos to visualize heart looping. V, ventricle; A, atrium. Correct D-loop, incorrect L-loop, and no looping are shown. 
One-tailed Fisher’s exact test: DMSO versus rotenone, N = 5, n = 89/103, **P = 0.0023; CTRL MO versus Cox5aa MO, N = 3, n = 131/99, ***P = 0.0001; 
DMSO versus DCHC, N = 4, n = 111/115, ****P < 0.0001; Gfp mRNA versus mPgc1a mRNA, N = 3, n = 72/79, *P = 0.0031. (H, I) Ambiguous spaw expres-
sion upon mitochondrial manipulation. Normal expression, left (cartoon); aberrant expression, right or both sides. One-tailed Fisher’s exact test: DMSO 
versus rotenone, N = 8, n = 117/137, ****P < 0.0001; CTRL MO versus Cox5aa MO, N = 4, n = 125/128, **P = 0.0047; DMSO versus DCHC, N = 3, n = 150/124, 
****P < 0.0001; Gfp mRNA versus mPgc1a mRNA, N = 5, n = 111/101, ***P = 0.0001. In D and E, red line indicates median. In F and H, scale bar: 50 µm.
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SLC25A5, SLC25A53, TIMM17B). In addition, the minor allele fre-
quency of variants present in ExAC indicates that they are ultra- 
rare and present at a significantly higher frequency in hetero taxy 
cases than within the general population (Table 1 and Supple-
mental Table 3). Next, we tested a more complex genetic inher-
itance model by investigating variant burden in order to analyze 
a potential association with heterotaxy. We considered the num-
ber of rare, predicted damaging variants in our cohort and 1000 
Genomes controls to establish the variant burden. Examining 1174 
mitochondria-associated genes identified a significant increase in 
damaging variant burden in the overall heterotaxy cohort as com-
pared with 1000 Genomes controls (Figure 4A). When stratified 
by ancestry, patients with European and African ancestries showed 
a significantly increased burden of rare damaging variants (Figure 
4A). To test the specificity of this finding, a comparison was per-
formed against exon-length–matched control gene lists including 
autism, cancer, and random disease-associated genes (Figure 4B 
and Supplemental Tables 2 and 4). A significantly higher burden of 
rare damaging variants was identified in mitochondria-associated 
genes in the heterotaxy cohort.
To evaluate these mitochondria-associated genes, homo-
logs of the homozygous and hemizygous patient variants were 
analyzed in zebrafish and human fibroblasts. Affected genes 
are expressed during early somitogenesis in zebrafish embryos 
when symmetry breaking is taking place (Supplemental Figures 
7 and 8). To functionally test the influence of the detected vari-
ants on ciliogenesis, we chose 6 candidate genes on the basis of 
predicted damage to the protein and expression in human fibro-
blasts (judged by proteinatlas.org; ref. 38) namely MTRR, CA5B, 
ACOX1, TAZ, OSBPL1A, and PHKA2. Then we targeted the can-
didate genes by siRNA-mediated KD in human fibroblasts and 
confirmed KD efficiency (Supplemental Figure 9). KD of each 
candidate gene led to reduced mitochondrial function as mea-
sured by a lower ATP content (Figure 5A). Consequently, and in 
line with our previous results, primary cilia were elongated after 
KD of candidate genes as compared with control cells (Figure 5, 
B and C), whereas the number of ciliated cells remained unaf-
fected (Supplemental Figure 10), indicating that affecting mito-
chondrial function via multiple pathways shares the outcome of 
elongated primary cilia in cells.
We next tested whether KD of these candidate genes in zebra-
fish embryos is sufficient to influence ciliogenesis and cause 
ciliopathy-like phenotypes. We therefore designed splice-blocking 
morpholinos (splMOs) for candidate genes for which it was possi-
ble, namely MTRR, OSBPL1a, PHKA2, or TAZ, and verified the tar-
geting efficiency of the splMOs (Supplemental Figure 11). Target-
ing of all tested candidate genes resulted in similar phenotypes as 
in the initial mitochondria manipulation experiments (Figure 5, D 
and E, and Figure 6, A and B). Morphant embryos also showed an 
increased occurrence of aberrantly looped hearts and misplaced 
pancreas as compared with control-injected embryos (Figure 5F, 
Figure 6C, and Supplemental Figures 12 and 13) suggesting that 
all tested genes are important for normal L-R asymmetry devel-
opment. This hypothesis was further strengthened by cilia mea-
surements in the KV. Cilia of morphant embryos were elongated, 
whereas the cilia number per KV was unchanged (Figure 5, G 
andH, and Figure 6D). Hence, KD of candidate genes identi-
compared with wild-type control cells, thus reflecting the same 
phenotype as observed after inhibition of mitochondrial respi-
ration (Figure 3, I and J). Formation of primary and motile cilia 
therefore respond the same to altered mitochondrial function. We 
hence propose that mitochondrial activity is precisely controlled 
to ensure correct cilium formation in general, and that increases 
and decreases in mitochondrial activity influence cilia length in 
inverse directions, which consequently reduces cilia functionality.
Our finding that mitochondrial dysfunction confers defects 
in cilium formation suggests that mutations in mitochondria- 
associated genes could cause situs anomalies such as heterotaxy. 
Ciliopathy phenotypes are rare in mitochondriopathy patients, but 
have been reported in certain cases (30–34). Nevertheless, there 
is phenotypic overlap in symptomatology. For example, patients 
with syndromic ciliopathies often possess phenotypes such as 
renal cysts or retinal degeneration that also occur in mitochon-
drial disorders (35). To further test our hypothesis, we performed 
whole-exome sequencing in a cohort consisting of 285 heterotaxy 
patients and carried out a focused analysis of 1174 genes listed in 
the Human MitoCarta2.0 (36) and the BCM-MitomeNGS (Baylor 
Genetics Laboratories) (Supplemental Table 2). We found either 
homozygous or X-linked hemizygous mutations in mitochondria- 
associated genes in 26 patients (9.12%; Table 1 and Supplemen-
tal Table 3). Six of these genes (MRPL44, MRPS25, MRPL38, 
NDUFA1, COQ9, TAZ) have previously been linked to known 
oxidative phosphorylation (OXPHOS) diseases (37). Overall, the 
genes are involved in diverse processes connected to mitochon-
dria, among them synthesis of cardiolipin (TAZ), mitochondrial 
translation (MRPL44, MRPS25, MRPL38), or mitochondrial ubi-
quinone biosynthesis (COQ9). Some of the detected rare variants 
have not been listed in population databanks such as the Exome 
Aggregation Consortium (ExAC) browser (MTRR, CA5B, IDH3G, 
Figure 2. Dosage of mitochondrial function reciprocally influences 
length of LRO cilia and disturbs flow. (A–D) Increased mitochondrial 
biogenesis decreases LRO cilia length. acTub, acetylated tubulin, cilia. 
(C) Cilia per KV. DMSO versus DCHC, 19/16 embryos, ***P = 0.0002; Gfp 
versus mPgc1a mRNA, 7/13 embryos. (D) LRO cilia length. DMSO versus 
DCHC, N = 19/16, n = 768/339; Gfp versus mPgc1a mRNA, N = 7/13,  
n = 230/357. ****P < 0.0001. (E–H) Inhibition of mitochondrial respira-
tion elongates LRO cilia. (G) Cilia number per KV. DMSO versus rotenone, 
11/15 embryos; CTRL MO versus Cox5aa MO, 20/20 embryos. (H) LRO cilia 
length. DMSO versus rotenone, N = 11/15, n = 643/700; CTRL MO versus 
Cox5aa MO, N = 20/20, n = 529/473. ****P < 0.0001. (I) Heat maps of flow 
speed. Orientation and color code are indicated. (J) LRO-flow speed after 
DMSO or DCHC (N = 13 and 12). Overall n = 722/607, anterior n = 399/319, 
*P = 0.0108, posterior n = 323/288, left n = 381/314, **P = 0.0169, right  
n = 342/293. (K) LRO-flow speed after DMSO or rotenone (N = 9 and 8). 
Overall n = 353/400, anterior n = 177/186, posterior n = 176/214, left  
n = 175/187, *P = 0.0422, right n = 178/214. (L) Ciliary beat frequency 
(CBF) after mitochondria stimulation. DMSO, 13 embryos, 113 cilia; DCHC, 
12 embryos, 109 cilia. (M) CBF after inhibition of mitochondria. DMSO, 
8 embryos, 66 cilia; rotenone, 9 embryos, 73 cilia; ****P < 0.0001. (N) 
dand5 (charon) expression at 10 ss. Shown are correct expression (right) 
and aberrant expression (both, left). Two-sided Fisher’s exact test: N = 3; 
DMSO versus DCHC (n = 67/51), ****P < 0.0001; DMSO versus rotenone 
(n = 82/77), **P = 0.0083. Two-tailed Welch’s t test in C and G (left); 
2-tailed Mann-Whitney test in D and G (right), H, and J–M. Scale bars in A, 
B, E, F, and N: 20 μm. Shown are mean ± SEM in panels C and H. Red line 
indicates median.
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fied in heterotaxy patients compromises elongation of primary 
as well as nodal cilia as judged by their increased length, ulti-
mately leading to disturbance of cilia-dependent processes such 
as symmetry breaking.
To further corroborate these observations we performed 
rescue experiments. We treated TAZ KD human fibroblasts with 
mitoTempo, a mitochondrion-specific scavenger of ROS that has 
been shown to restore mitochondrial function in this setting (39). 
This also worked in our hands as judged by increased cellular ATP 
levels in TAZ KD cells (Supplemental Figure 14). Consequently, 
mitoTempo treatment of TAZ KD cells caused shortening of pri-
mary cilia, while the number of ciliated cells remained the same 
(Supplemental Figure 14). Thus, we propose mitochondrial dys-
function after TAZ loss-of-function in human fibroblasts as the 
likely cause for elongation of primary cilia.
Next, we aimed to rescue ciliopathy-like phenotypes in zebra-
fish. We knocked down Taz and Mtrr and coinjected capped RNA 
encoding either the wild-type protein or the variant as detected in 
the heterotaxy patients. KD of both candidate genes caused pericar-
dial edema or curved tail (Figure 6B and Supplemental Figure 15). 
Moreover, whereas injection of RNA encoding the wild-type pro-
tein was able to at least partially rescue these defects, RNA encod-
ing the patient rare damaging variants failed to do so (hTAZ-R253Q 
or hMTRR-R552Q; Figure 6B and Supplemental Figure 15). Coin-
jection of RNA encoding wild-type TAZ further restored normal 
heart looping and pancreas positioning in Taz morphant embryos, 
whereas RNA encoding hTAZ-R253Q did not (Figure 6C and Sup-
plemental Figure 13). Similarly, wild-type MTRR restored L-R 
asymmetry in zebrafish depleted of Mtrr, but the patient variant 
hMTRR-R552Q did not (Supplemental Figure 16). Finally, although 
Figure 3. Dosage of mitochondrial function reciprocally influences length and function of primary cilia in human fibroblasts. (A, B) Increased mitochon-
drial function causes shortening of primary cilia of human fibroblasts. Representative images of cells treated with DMSO or DCHC. Cilia are visualized by 
staining for acetylated Tubulin (acTub, green), while COX IV (red) stains mitochondria. (C, D) DCHC or rotenone treatment does not change the number of 
ciliated cells. Paired 2-tailed t test; DMSO versus DCHC, N = 3, n = 248/246, P = 0.3517; DMSO versus rotenone, N = 3, n = 253/249, P = 0.1361. Shown are mean 
± SEM. (E, F) DCHC or rotenone treatment alters the length of cilia. Two-tailed Mann-Whitney test; DMSO versus DCHC, N = 3, n = 96/105, ****P < 0.0001; 
DMSO versus rotenone, N = 3, n = 106/103, **P = 0.0011. Red line indicates median. (G, H) DCHC or rotenone treatment reduces the cellular ability to induce 
the Hedgehog-target gene GLI1 upon stimulation with an agonist of the Hh pathway. Paired, 2-tailed t test; DMSO versus DCHC, n = 4, *P = 0.0155; DMSO 
versus rotenone, N = 3, **P = 0.0277. Shown are mean ± SEM. (I, J) Patient-derived human fibroblasts carrying mutations in MPV17 or NFU1 extend longer 
primary cilia as compared with control cells (WT). Acetylated Tubulin (acTUB, red) stains cilia, while γTubulin (γTUB, green) stains centrioles. Kruskal- 
Wallis test with Dunn’s multiple comparison test, N = 3, n = 104/95/107, WT versus MPV17, **P = 0.0028; WT versus NFU1, ***P = 0.0002. Red line indicated 
median. In A, B, and I, scale bars: 10 μm.
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the number of cilia per KV was unchanged, KD of Taz in zebrafish 
embryos triggered elongation of LRO cilia, which was fully rescued 
by coinjection of RNA encoding hTAZ (Figure 6D). In contrast, the 
patient variant hTAZ-R253Q was not able to rescue LRO cilia elon-
gation, suggesting that this variant at least contributed to the devel-
opment of heterotaxy in the respective patient (Figure 6D).
So far, dysfunctional Taz protein has mainly been associated 
with Barth syndrome, a rare X-linked syndrome characterized by 
early-onset skeletal and cardiac myopathies due to mitochondrial 
remodeling (40). In zebrafish, loss of Taz had been associated 
with a general impairment of cardiac function such as pericar-
dial edema, which we also observed, and bradycardia (41). We 
therefore assessed the heart rate in Taz morphant embryos and 
counted a slight but significant reduction in heartbeats per minute 
(Supplemental Figure 17). Only coinjection of RNA encoding the 
wild-type hTAZ rescued this phenotype, while coinjection of RNA 
encoding the patient variant hTAZ-R253Q failed to do so (Supple-
mental Figure 17). Therefore, our results suggest that variants of 
the TAZ gene have the potential to impact the organism at time 
points earlier than previously described and on multiple levels.
Discussion
Mitochondria are historically best known for their role in energy 
production. Here we show that mitochondrial function is also con-
nected to cilium formation and function. We found a significant 
reduction in mtDNA selectively in a cohort of heterotaxy patients 
and consequently manipulated mitochondrial function in zebra-
fish embryos, human fibroblasts, and Tetrahymena thermophila. 
In response to such manipulation, we detected heterotaxy-like 
pheno types and identified cilia length aberrations, which inversely 
correlate with diminished or increased mitochondrial function. KD 
of mitochondria-associated candidate genes identified in a sec-
Table 1. Rare variants in mitochondria-related genes detected in heterotaxy patients
Gene name Variant Identifier CADD PHRED  
score
Tools predicting 
damaging variant 
(N = 6)A
Homozygous or 
X-linked variant
Allele frequency  
in heterotaxy 
cohort
Allele frequency  
as reported by 
ExACB
P value  
(Fisher’s exact 
test)C
ACOX1 c.1771C > T rs35629489 29 ***** hom 0.00351 0 <0.0001
ACSM2A c.1576G > A rs144620533 24.6 **** hom 0.00351 0.0000164 0.0001
ADCK4 c.1055C > G rs36012476 2.2 * hom 0.00351 0.0015525 0.2232
AKAP1 c.988A > G rs34535433 0.1 NA hom 0.00351 0.0004340 0.0274
CHCHD3 c.616G > A rs147544227 17.3 * hom 0.00351 0 <0.0001
COQ9 c.79C > G rs140264612 19.7 ** hom 0.00351 0.000101 0.002
MRPL38 c.341G > A rs147331508 15.6 *** hom 0.00351 0 <0.0001
MRLP44 c.38A > G rs534596036 0.626 * hom 0.00351 0 <0.0001
MRPS25 c.470A > G rs186043878 19.4 **** hom 0.00351 0 <0.0001
MTRR c.1655G > A NA 32 ***** hom 0.00351 NA NA
OSBPL1A c.2411G > A rs145164093 19.4 ** hom 0.00351 0.0000329 0.0003
ALAS2 c.1559C > T rs201062903 28.8 ***** X-linked 0.00239 0.0006505 0.2418
ALAS2 c.1718C > T rs201799139 22.1 ****** X-linked 0.00239 0.0000852 0.0418
APEX2 c.421C > T rs2301416 18.1 * X-linked 0.00239 0.0011337 0.3840
APEX2 c.1123C > T rs376594966 12.6 * X-linked 0.00239 0.0000117 0.0097
CA5B c.704C > T NA 27.5 ****** X-linked 0.00239 NA NA
IDH3G c.1080 + 14C > T NA 4.7 NA X-linked 0.00239 NA NA
NDUFA1 c.94G > C rs1801316 24.1 ** X-linked 0.00477 0.002349 0.2611
PHKA1 c.3331G > A NA 32 ****** X-linked 0.00239 0.0000252 0.0157
PHKA2 c.2578C > T rs375687463 35 ****** X-linked 0.00239 0.00009 0.0487
SLC25A5 c.464G > A NA 14.2 NA X-linked 0.00239 NA NA
SLC25A53 c.149A > G NA 24.1 **** X-linked 0.00239 NA NA
SLC25A53# c.-31 - 9204dupC NA 25.7 NA X-linked 0.00239 NA NA
SLC25A53# c.-31 - 9258C > T NA 26.6 *** hom (female) 0.00477 NA NA
TAZ c.758G > A NA 23.7 ***** X-linked 0.00239 0 0.0048
TIMM17B c.124G > A NA 20.6 ** X-linked 0.00239 NA NA
Whole-exome sequencing data of 285 patients (134 females and 151 males) were analyzed regarding mutations in genes listed in the Human MitoCarta2.0 
(36) and the BCM-MitomeNGS (Baylor Genetics Laboratories). Only homozygous (hom) or hemizygous rare variants were taken into account. Listed are 
gene names, markers indicating location and type of rare variant, and the identifier of the altered allele (2 rare variants indicated by # are located in the 
5′-untranslated region of SLC25A53, which coincides with the translated region of ZCCHC18). Severity of mutations was assessed via Combined Annotation 
Dependent Depletion (CADD PHRED score) and 6 dbNSFP functional prediction programs (SIFT, Polyphen2 HVAR, MutationTaster, MutationAssessor, 
FATHMM, and FATHMM MKL Coding). AThe number of asterisks indicates the number of tools that predict the mutations to be damaging. BThe altered 
allele frequency in the heterotaxy cohort was calculated and compared with the frequency of homozygous occurring alleles as reported on the ExAC 
browser or the hemizygous occurring alleles as listed by ExAC, when X-linked alleles were concerned. CSignificance was calculated via 2-tailed Fisher’s exact 
test. NA, not available; damage prediction only available for missense variants.
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dent fashion (42). Knock out of Kif19a consequently causes 
longer cilia in different organ systems of the mouse (42). 
Lower abundance of ATP due to mitochondrial dysfunction 
could reduce the processivity of Kif19a at the tips of cilia 
and hence attenuate Kif19a’s length-restricting activity, 
leading to elongated cilia. Vice versa, elevated ATP levels 
potentially increase Kif19a activity, leading to shorter cilia.
However, mitochondria have additional important 
functions besides energy production. Indeed, the rare 
genetic variants we detected in exome-sequencing data 
of heterotaxy patients include genes affecting very diverse 
mitochondrial functions. These include among others 
heme biosynthesis (ALAS2), DNA repair (APEX2), mito-
chondrial cardiolipin production (TAZ), mitochondrial 
membrane transport (TIMM17B), lipid metabolism and 
ROS regulation (ACOX1), mitochondrial protein transla-
tion (MRPL38, MRPL44, MRPS25), ubiquinone synthesis 
(COQ9, ADCK4), methionine synthesis (MTRR), glycogen 
storage (PHKA1, PHKA2), lipid transfer (OSBPL1A), and 
mitochondrial HCO3– production (CA5B). Yet despite their 
diverse functions, KD of all investigated candidate genes 
reduced ATP content and simultaneously caused longer 
cilia in our functional tests. This finding was further com-
plemented by our observation of longer cilia in patient- 
derived human fibroblasts with defects in mitochondrial 
function and maintenance, respectively. Therefore, distur-
bances of mitochondria on very diverse functional levels 
seem to funnel into the same phenotype of elongated cilia. 
The question that remains is whether reduced ATP levels 
are the common trigger for cilia elongation. This could be 
a possibility, since KD of diverse candidate genes led to 
attenuated ATP levels. Moreover, different mitochondrial 
processes not directly involved in respiration have been 
shown to impact ATP synthesis: fatty acid metabolism, for 
instance, is coupled to ROS generation and the respiratory 
chain. In mouse cardiomyocytes, lipid overload results in 
increased respiratory activity and hence ATP production. 
Extended exposure to excessive lipids, on the other hand, 
results in the production of ROS (43). Calcium overload in 
mitochondria also impacts ATP production through mito-
chondrial permeability transition pore opening and sub-
sequent membrane depolarization (44). Mitochondrial 
protein translation is coupled to ATP synthesis, too, as loss 
of the eukaryotic translation initiation factor 2B subunit 5 
results in a reduction of respiratory chain components on 
a protein level and subsequently a decrease in ATP synthe-
sis (45). Similarly, a very recent, large-scale Crispr/Cas9 approach 
identified deficiencies in mitochondrial protein translation as one 
of the prime causes of impaired respiratory chain activity although 
the 5 complexes of the respiratory chain are largely encoded by 
nuclear genes (37). Interestingly, 3 genes for which we detected 
homozygous rare damaging genetic variants, namely MRPL38, 
MRPL44, and MRPS25, regulate mitochondrial translation and 
are known as OXPHOS disease genes (37). Methionine metabo-
lism has also been linked to mitochondrial respiratory function. 
Methionine is enriched in the intramembraneous space and serves 
as antioxidant for the respiratory chain (46). The mitochondrial 
ond cohort of heterotaxy patients attenuated ATP abundance in 
human fibroblasts and conferred cilium elongation in fibroblasts 
and zebrafish, resulting in ciliopathy-like phenotypes including 
L-R asymmetry defects. Patient variants failed to rescue KD- 
induced phenotypes, indicating that the identified rare variants 
may be contributors or even causes for the development of hetero-
taxy. Yet, how could reduced ATP levels cause elongation of cilia? 
Inhibition of energy-dependent processes that reduce cilia length 
possibly explains the observed phenotype. A candidate factor could 
be the kinesin KIF19A, which locates to the tip of cilia and depo-
lymerizes ciliary microtubules from the plus end in an ATP-depen-
Figure 4. Increased burden of rare damaging variants in mitochondria-associated 
genes in patients with heterotaxy. (A) Variant burden analysis in mitochondria- 
associated genes in the heterotaxy cohort versus 1000 Genomes controls. Burden 
is presented as ratio of damaging/tolerated rare variants. Wilcoxon rank sum test, 
2-sample test with normal approximation; overall n = 2503/284, ****P < 0.0001; 
European (EUR), n = 502/190, *P = 0.0248; African (AFR), n = 661/41, **P = 0.0109; 
Admixed American (AMR), n = 347/32, P = 0.1502; Asian, n = 993/21, P = 0.106. Arrows 
indicate extreme outliers which are included in analysis but not shown. (B) Variant 
burden analysis in mitochondria-associated genes compared with control genes 
in the heterotaxy cases. Nonparametric comparisons for each pair using Wilcox-
on method; n = 283; mitochondria-associated genes versus autism genes, ****P 
< 0.0001; cancer genes, ****P < 0.0001; random disease genes A, **P = 0.0012; 
random disease genes B, ***P = 0.0015. Data sets are represented in outlier box 
plots indicating median and 25th and 75th quantile, respectively. Whiskers indicate 
first quartile –1.5* (interquartile range) and third quartile +1.5* (interquartile range), 
respectively. Dots indicate outliers, and arrows indicate extreme outliers which are 
included in analysis but not shown.
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
2 8 4 9jci.org   Volume 129   Number 7   July 2019
Figure 5. Cilia length and function defects upon loss-of-function of heterotaxy patient-derived genes. (A) KD of candidate genes reduces cellular ATP. One-
way ANOVA with Holm-Sidak comparison, n = 10, all compared with control siRNA (siCTRL): ****P < 0.0001 (TAZ, OSBPL1A, MTRR, PHKA2), ***P < 0.0001 
(CA5B), **P = 0.0049 (ACOX1). Red line indicates median. (B, C) KD of candidate genes causes longer cilia. Cartoon illustrates staining for cilia (acTub, red), 
the basal body (BB, green), and the nucleus (blue). Scale bar: 10 μm. Kruskal-Wallis test with Dunn’s multiple comparison, N = 3, n = 95/99/96/96/98/94/100, 
all compared with siCTRL: ****P < 0.0001 (CA5B, TAZ, OSBPL1A, MTRR), **P = 0.0049 (ACOX1). Red line indicates median. (D) Representative images of 48 
hpf zebrafish embryos, which were either noninjected (NI), control-injected (CTRL MO), or injected with MO targeting splice sites (spMO) in Mtrr, Phka2, and 
Osbpl1a, respectively. (E) Quantification of pericardial edema and body curvature in embryos. One-way ANOVA with Holm-Sidak comparison; N = 7/7/3/4/4,  
n = 196/178/52/102/109, all compared with CTRL MO. Pericardial edema: ****P < 0.0001 (Mtrr splMO, Phka2 splMO); *P = 0.0144 (Osbpl1a splMO); curved tail: 
****P <0.0001 (Mtrr splMO), ***P =0.0008 (Osbpl1a splMO), **P = 0.0003 (Phka2 splMO). (F) KD of candidate genes increases frequency of aberrant heart 
looping. Two-sided Fisher’s exact test; N = 9/9/3/6/4; n = 227/200/50/143/104; all compared with CTRL MO: ****P <0.0001 (Mtrr splMO, Phka2 splMO),  
***P = 0.0006 (Osbpl1a splMO). (G) KD of candidate genes does not alter the number of cilia per KV. One-way ANOVA with Holm-Sidak comparison, n = 
15/12/13/15. (H) KD of candidate genes confers elongation of LRO cilia. Kruskal-Wallis test with Dunn’s multiple comparison test; n = 261/209/268/343; all 
compared with CTRL MO, ****P < 0.0001. Red line indicates median. Scale bars: 10 μm (B) or 500 μm (D). Shown are mean ± SEM in E and G.
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(50–52). Interestingly though, mitochondria and cilia organelles 
have not previously been associated mechanistically as a possible 
common link in CHD causation. For example, TAZ loss-of-function 
variants, which cause mitochondrial insufficiencies, have been asso-
ciated with fetal and early postnatal onset cardiomyopathy, but not 
with cilia defects, although Taz knockout mice display spermatogen-
esis defects and Drosophila flies devoid of functional taz were sterile, 
both being defects suggesting potential abnormal cilia function (53, 
54). In a recent ENU screen for novel predisposing genes for CHD (8), 
12 of the 61 human homologs of the identified genes localize to mito-
chondria (according to genecards.org, ref. 55), which corresponds to 
19.7% of the identified susceptibility genes. This suggests that patho-
genic rare variants in genes connected to mitochondria can contrib-
ute to the development of CHD at least in the murine system. More-
over, at least one of the laterality genes (ATIC), for which genetic 
variations were reported in a large human cohort of CHD (49), also 
localizes to mitochondria.
A phenotypic overlap between mitochondrial disorders and 
cilia-related abnormalities exists (e.g., nephronophthisis, cranio-
facial anomalies, microcephaly, and obesity) (18, 30–35). A pre-
vious study has identified pathogenic variants of mtDNA at ele-
vated frequencies in cardiac tissue from patients suffering from 
CHD (50). The connection of mitochondrial function and cilio-
methionine cycles further provide the source of methyl groups 
for epigenetic changes in DNA (47). Hypermethylation of the 
Cox5a promoter has been linked to reduced expression of Cox5a, 
which we also depleted to inhibit respiratory activity in the LRO 
of zebrafish embryos, and thus reduced activity of the respiratory 
chain, resulting in less ATP synthesis (48). Hence, the assessment 
of cellular ATP content may serve as a readout of mitochondrial 
function, and potentially also as a diagnostic in afflictions con-
nected to impaired cilia formation. Vice versa, manipulation of 
ATP content could possibly be a means of correcting cilia defects. 
Moreover, we measured strikingly attenuated mtDNA content 
specifically in peripheral blood samples of heterotaxy patients as 
opposed to samples of patients with CHD not connected to cili-
ary dysfunction or from healthy subjects. This might present as an 
additional diagnostic tool to recognize ciliopathies, as peripheral 
blood is easily accessible and measurement of mtDNA content 
straightforward. However, further studies are needed to scrutinize 
and verify the usefulness and robustness of such diagnostic and 
therapeutic approaches.
Cilia defects can give rise to CHD (8, 49). In addition, small 
studies and case reports have highlighted that certain cases of mito-
chondriopathies also display congenital heart malformations and 
patients with CHD may have reduced mitochondrial DNA content 
Figure 6. Patient rare variants cannot rescue 
ciliopathy-like phenotype. (A) Representative 
images of 48 hpf zebrafish embryos, which 
were either noninjected (NI), control-injected 
(CTRL MO), or injected with MOs targeting Taz 
(Taz MOs), respectively. Optionally, capped RNA 
encoding wild-type hTAZ or hTAZ-R253Q were 
coinjected with TAZ MOs. Scale bar: 500 μm. (B) 
Quantification of pericardial edema and curved 
tail after Taz KD. N = 5, n = 119/108/119/124/109; 
pericardial edema, RM 1-way ANOVA with 
Sidak’s multiple comparison, CTRL MO versus 
Taz MOs, **P = 0.0064; Taz MOs versus Taz 
MOs + hTAZ, *P = 0.0328; MOs + hTAZ versus 
Taz MOs + R253Q, ***P = 0.0037; curved tail, 
Friedman test with Dunn’s comparison, CTRL 
MO versus Taz MOs, ****P = 0.0055. (C) Rescue 
of heart looping. N = 5; n = 119/94/116/118/112; 
2-sided Fisher’s exact test; CTRL MO versus Taz 
MOs, ****P < 0.0001; Taz MOs versus Taz MOs 
+ hTAZ, ***P = 0.0002; Taz MOs versus Taz MOs 
+ R253Q, P = 0.0828; Taz MOs + hTAZ versus 
Taz MOs + R253Q, ****P < 0.0001. (D) Altered 
expression of TAZ does not affect number of cilia 
per KV. Kruskal-Wallis test with Dunn’s multiple 
comparison, n = 8/8/8/7. Coinjection of RNA 
encoding rare variant of hTAZ as detected in het-
erotaxy patients does not rescue LRO cilia length 
in TAZ morphant zebrafish. Kruskal-Wallis test 
with Dunn’s multiple comparison; N = 8/8/8/7, 
n = 340/295/315/326; CTRL MO versus Taz MOs, 
****P < 0.0001; Taz MOs versus Taz MOs + 
hTAZ, ****P < 0.0001; Taz MOs versus Taz MOs 
+ R253Q, P = 0.737; Taz MOs + hTAZ versus Taz 
MOs + R253Q, ****P < 0.0001. Shown are mean 
± SEM and the median as red line, respectively, 
in B and D.
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GGAAGAT), otherwise the standard control MO of Genetools was 
used. Injected mRNAs were generated from linearized plasmids using 
the mMessage mMachine SP6 Kit (Ambion). To stimulate mitochon-
drial biogenesis, embryos were treated between 6–10 hours postfer-
tilization (hpf) with 50 μM DCHC (dissolved in DMSO). Inhibition of 
respiration was achieved by treatment of embryos between 10–13 hpf 
with 0.1 μM rotenone (dissolved in DMSO, both from Sigma-Aldrich).
Cell culture. The following cell lines were used in this study: hTERT 
immortalized primary human fibroblast cell line 1BR3 (wild-type; Uni-
versity of Sussex), patient-derived cell lines MITO_HH0013 (carry-
ing a homozygous pathogenic variant in MPV17) and MITO_HH009 
(carrying a homozygous pathogenic variant in NFU1) (both collected 
at University Medical Center Hamburg-Eppendorf). Cells were cul-
tured in MEMα containing 10% FBS and 1% penicillin/streptomycin 
(all from Life Technologies) at 5% CO2 and 37°C. To obtain synchro-
nous cultures in G0, cells were kept 2 to 3 days in starving medium 
(MEMα containing 0.1% FBS and 1% penicillin/streptomycin). Cells 
were treated with 0.5 μM Smoothened agonist (SAG; Enzo) during the 
last 24 hours of culturing to stimulate Hedgehog signaling activity. For 
immunofluorescence, cells were seeded on cover slips at a density of 
1.7 × 104 cells per cm2, optionally synchronized in G0, and fixed with 
either 4% PFA or chilled methanol. KD of candidate genes was per-
formed with custom made pools of 30 individual siRNAs all targeting 
an individual gene of interest or the negative control siPOOL 5 (all 
from siTOOLs Biotech): MTRR (NCBI gene ID 4552), ACOX1 (NCBI 
gene ID 51), OSBPL1A (NCBI gene ID 114876), CA5B (NCBI gene ID 
11238), PHKA2 (NCBI gene ID 5256), TAZ (NCBI Gene ID 6901). 
Transfection of siRNA pools was carried out with Lipofectamine 
RNAiMAX (Thermo Fisher Scientific). Mitochondrial biogenesis was 
stimulated with 50 μM DCHC (dissolved in DMSO; Sigma-Aldrich). 
To this end, cells were treated with 50 μM DCHC for 48 hours after 
transfection; the last 24 hours were in starving medium if cells were 
to be synchronized in G0. Inhibition of respiration was achieved with 
rotenone treatment (100 nM). Treatment with MitoTempo (SML0737, 
Sigma-Aldrich) was carried out during synchronization with starving 
medium at a final concentration of 50 nM.
Mitochondrial DNA content. RNase A–treated genomic DNA from 
blood samples (heterotaxy patients and healthy subjects; Figure 1A) 
was diluted to a concentration of 5 ng/μl. Triplicate reactions were 
set up containing genomic DNA, iTaq Universal SYBR Green Super-
mix (Bio-rad), and one of the following primer pairs: (a) targeting the 
sequence of the mitochondrial-encoded 12s ribosomal RNA gene 
(Genebank ID 4549; F, 5′-CTAACCCCAGGGTTGGTCA; R, 5′-TAC-
GCCGGCTTCTATTGACT) or (b) the exon-intron transition of exon 1 
of the nuclear gene MLH1 (ENST00000231790.6; F, 5′-GTTCGTGG-
CAGGGGTTATT; R, 5′-TCCCTCCGTACCAGTTCTCA). Amplifica-
tions were carried out in an ABI PRISM 7300 Sequence Detection Sys-
tem (Applied Biosystems) or a LightCycler 480 Instrument II (Roche). 
Levels of the mitochondrial encoded 12s ribosomal RNA gene were 
compared with the nuclear encoded MLH1 gene to assess abundance 
of mitochondrial DNA.
ATP measurement. The ATPlite Luminescence ATP Detection 
Assay system (Perkin Elmer) was used for ATP measurements. Mito-
chondrial function or biogenesis was manipulated in zebrafish embryos 
and human fibroblasts as described above. Zebrafish em bryos of 
the desired stage were collected and flash frozen in aliquots of 2 
embryos. For measurements, embryos were placed on ice, imme-
genesis identified by the current study raises the possibility that 
pathogenic variants in nuclear-encoded mitochondrial genes 
lead to reduced mitochondrial function and also defective cilia. 
These data together indicate that mutations in nuclear- as well as 
mitochondrial-encoded genes may contribute to defects trig-
gered by dysfunctional cilia such as CHD. Thus, in order to detect 
the disease-causing rare variants in patients presenting with 
ciliopathy-like features, mitochondria-related genes should also 
be taken into consideration.
The data demonstrate that manipulation of mitochondrial 
function in multiple organisms has the potential to alter genera-
tion of cilia. Although syndromic and Mendelian forms of CHD 
explain a proportion of disease in humans, many cases of CHD 
behave as a complex trait. The increased burden of rare damag-
ing variants in mitochondria-associated genes identified in our 
heterotaxy cohort suggests that the accumulation of protein- 
altering variants that collectively disrupt mitochondrial function 
act as potential susceptibility factors for heterotaxy and CHD.
Methods
Patient cohorts. Two heterotaxy cohorts were used in this study: To 
assess the content of mtDNA, DNA samples from heterotaxy patients 
(n = 69), patients suffering from non–heterotaxy-related CHDs (n = 20, 
Supplemental Table 1) and healthy subjects (n = 78, unaffected indi-
viduals, mostly parents of patients) provided by the German National 
Register for Congenital Heart Defects (Competence Network for Con-
genital Heart Defects, Berlin, Germany) were used. DNA samples 
were from whole blood and isolated by standard procedures. The local 
ethics committee in Berlin approved collection and distribution (due 
to German practice, no ethnicity data were collected). Medical records 
regarding the heart phenotype and situs were provided with the sam-
ples. The local ethics committee in Ulm approved mtDNA content 
analyses for this cohort.
Information from a second cohort (n = 285) with phenotype infor-
mation including imaging and diagnostic studies, clinical genetic test-
ing results, and pathology results was collected at Cincinnati Children’s 
Hospital Medical Center (CCHMC) under a protocol approved by the 
CCHMC Institutional Review Board. The cohort consisted of patients 
with a diagnosis of heterotaxy or heterotaxy-spectrum heart defects. 
DNA samples from whole blood were isolated by standard procedures.
Zebrafish husbandry and manipulation. Zebrafish wild-type strains 
AB and EK (gift of Kenneth D. Poss, Duke University Medical Cen-
ter, Durham, NC) were maintained under a 14-hour light, 10-hour 
dark cycle and fed a standard diet. Embryos were generated by nat-
ural matings and allowed to develop to the desired stages at 28.5°C. 
Microinjections into zebrafish eggs were carried out with a Femtojet 
microcompressor (Eppendorf), pulled capillaries, and a Narishige 
micromanipulator. Antisense morpholino oligonucleotides (MOs) or 
capped RNAs were injected into the yolk at the 512–1000 cell stage 
to specifically target cells giving rise to the KV (56). The Cox5aa 
MO and the Taz ATG MO have been previously described (18, 41). 
Hetero taxy candidate genes were targeted with the following MOs: 
Mtrr splMO (5′-GCTTGAGAAAGATGTGGAAAAATAT), Osbpl1a 
splMO (5′-AAGGATGTGTTTTACCCTTGCAGTT), Phka2 splMO 
(5′-CCACCTGCAGTTACATTGACGTG), and Taz splMO (5′-ACCA-
CACTAAGACATTGTAACAGAG). For Cox5aa experiments, a 5-bases 
mismatch MO was used as a control (5′-AGAGTCGAACGCCGGGTC-
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Aldrich) and COX IV (1:1000, clone 3E11; Cell Signaling Technology) 
were used. Fluorescent dye–labeled secondary antibodies were used to 
detect bound primary antibodies (Life Technologies). Stained embryos 
were dissected and flat-mounted between 2 cover slips in Vectashield 
medium containing Dapi (Vectorlabs). Cells were also mounted in 
Vectashield medium containing Dapi. Confocal stacks were generated 
with increments of 0.25 μm (cells) or 0.4 μm (zebrafish embryos) with 
sequential laser excitation and rendered into single-plane projections 
for analysis. The entire length of cilia was tracked with the help of an 
Intous3 6 × 8 USB tablet (Wacom) and measured with ImageJ.
qPCR. Total RNA was extracted from human fibroblasts or zebra-
fish embryos using the Quick-RNA MiniPrep kit (Zymo Research), 
which includes genomic DNA removal columns and on-column DNa-
seI digest of remaining genomic DNA. Reverse transcription was car-
ried out using the ProtoScript II First Strand cDNA Synthesis Kit (New 
England Biolabs) or Superscript II Reverse Transcriptase (Thermo Fish-
er Scientific). Expression levels of specific mRNAs were assessed with 
the Universal Probe Library system (Roche), ABsolute QPCR Mix (with 
ROX, Thermo Fisher Scientific), and the following primers (and probes): 
TAZ (probe 68; F, 5′-TTCCCCTCATTCTCTGCTTG; R, 5′-CACTC-
CCACTTCTTCAGCTTG), PHKA2 (probe 25; F, 5′-TCGTGGATG-
GAGATGGTAGG; R, 5′-TTGGCGTTGAAAGAAGTGTG), OSBPL1A 
(probe 3; F, 5′-GAGTCTAAATCCAAGGTCATCTCG; R, 5′-GGACT-
GGAAAAGCTTTCAACC), MTRR (probe 2; F, 5′-TGGCCATAT-
TCTTTGCATCTC; R, 5′-CAGCAGGTGGCGAGAATC), CA5B (probe 
3; F, 5′-CAAATCTGACTGCGTTCCAA; R, 5′-ACACCGTGGACAG-
CAAATG), ACOX1 (probe 76; F, 5′-TCCTGGGTTTCAGGGTCATA; R, 
5′-CCCAGACAGAGATGGGTCAT), SDHA (probe 80; F, 5′-GGACCT-
GGTTGTCTTTGGTC; R, 5′-CCAGCGTTTGGTTTAATTGG), GLI1 
(probe 7; F, 5′-CCAGCCAGAGAGACCAACAG; R, 5′-CCCGCTTCTTG-
GTCAACTT), acox1 (probe 3; F, 5′-TCTGAACATCGCCCAGGTG; 
R, 5′-GGCATATGCAGTAGCCAGAAG), caVa (probe 51; F, 5′-TCCG-
CAAACTATCAATCCTCA; R, 5′-TCAATAGGTGACTGTCGATCTCC), 
mtrr (probe 17; F, 5′-TGCCGTCACAAAGACAAAGA; R, 5′-CTCAGG-
GTCCCATTATGCAC), osbpl1a (probe 82; F, 5′-CTGTTGGAGGAC-
CGAGTCA; R, 5′-CTGGCATCCCTGAGGAAC), phka2 (probe 159; F, 
5′-GGCACTTACACTTTTACTCCACAG; R, 5′-TGGTTATCCAGAG-
CCAAGTAGAA), taz (probe 62; F, 5′-GGCAGTTGTGGAACCTTAA-
CA; R, 5′-GGAGTGAAATTCTCTTGTGAAACA), gapdh (probe 147; F, 
5′-CAGGCATAATGGTTAAAGTTGGTA; R, 5′-CATGTAATCAAGGT-
CAATGAATGG). Reactions were run in triplicate in a LightCycler 480 
Instrument II and results were analyzed with LightCycler 480 Software, 
version1.5 (both from Roche).
Exome sequencing and variant analyses. Whole-exome sequencing 
(WES) was performed on an Illumina HiSeq2500 sequencer using 
the Nimblegen SeqCap EZ Human Exome kit at the CCHMC DNA 
Sequencing and Genotyping core. Data are deposited at the NCBI 
Database of Genotypes and Phenotypes (dbGAP) under the refer-
ence phs001814.v1.p1. Alignment, preprocessing, and variant calling 
was performed using the Genome Analysis Toolkit (GATK) at the 
CCHMC Bioinformatics Core. Variant filtering and annotation was 
done using Golden Helix SVS software. For the initial variant assess-
ment and definition of mitochondrial disease incidence, genes were 
annotated against RefSeq 105 v2 and restricted to homozygous and 
X-linked variants present in exon regions, which resulted in protein 
alterations including missense, frameshift, splice site, stop loss, stop 
gain, and small in-frame insertions and deletions. Only variants with 
diately lysed in 30 μl mammalian cell lysis buffer (component of the 
kit), and transferred to a well of a black, Nunclon Delta Surface flat- 
bottom 96-well plate (Thermo Fisher Scientific). Human fibroblasts 
were plated in the same type of cell plate at a density of 1000 cells per 
well and were lysed by addition of 30 μl mammalian cell lysis buffer 
to 50 μl of medium and shaking at 400 rpm for 5 minutes at room 
temperature. To both types of lysates, 30 μl of substrate solution was 
added and shaken at 400 rpm for 5 minutes at room temperature. 
Wells containing no lysate or defined amounts of ATP were treated 
in parallel for blank controls as well as calculation of a standard 
curve. After 15 to 90 minutes of incubation in the dark, luminescence 
was measured using an infinite M200 plate reader and i-control 1.6 
software (both from Tecan).
Measurement of oxygen consumption rate (OCR). The OCR was 
measured with a Seahorse XF96 device (Agilent). Zebrafish embryos 
were treated between 6–10 hpf with 50 μM DCHC (dissolved in 
DMSO) or vehicle. At tailbud stage, embryos were transferred to a 
XF96 plate (5 embryos per well). Basal oxygen consumption was 
measured 3 times over 2 minutes.
Whole mount in situ hybridization. Embryos were allowed to 
develop to the indicated stages. To prevent pigmentation, embryos 
older than 22 somites were treated with 0.003% 1-phenyl-2-thiourea 
(PTU, Sigma-Aldrich). At desired stages, the chorion was removed 
and embryos fixed in 4 % paraformaldehyde at 4°C overnight. In situ 
hybridizations were carried out following standard protocols (57). 
In situ probes were labelled with DIG by in vitro transcription from 
linearized plasmids encoding for the following mRNAs or parts 
thereof: charon (NM_212969), southpaw (spaw; NM_180967), cardiac 
myosin light chain 2 (cmlc2; AF425743.1), insulin (ins; NM_131056), 
5-methyltetrahydrofolate-homocysteine methyltransferase reductase 
(mtrr; ENSDARG00000045398), mitochondrial ribosomal pro-
tein L38 (mrpl38; NM_212945.1), coenzyme Q9 homolog (coq9; 
NM_001098746.1), mitochondrial ribosomal protein S25 (mrps25; 
NM_001017590.1), coiled-coil-helix-coiled-coil-helix domain con-
taining 3a (chchd3a; NM_214804.2), mitochondrial ribosomal pro-
tein L44 (mrpl44; NM_001030260.2), A kinase (PRKA) anchor pro-
tein 1b (akap1b; NM_001098179.2), acyl-CoA oxidase 1, palmitoyl 
(acox1; NM_001005933.2), oxysterol binding protein-like 1A (osbpl1a; 
BC162978.1), translocase of inner mitochondrial membrane 17 homo-
log B (yeast) (timm17b; NM_001113593.1), APEX nuclease (apurinic/
apyrimidinic endonuclease) 2 (apex2; NM_200146.1), aminolevuli-
nate, delta-, synthase 2 (alas2; NM_131682.2), solute carrier family 
25 member 5 protein (slc25a5; AF506216.1), NADH dehydrogenase 
(ubiquinone) 1 alpha subcomplex, 1 (ndufa1; NM_001002153.3), isoc-
itrate dehydrogenase 3 (NAD+) gamma (idh3g; NM_001243172.1), 
tafazzin (taz; NM_001001814.1), phosphorylase kinase, alpha 1b 
(phka1b; ENSDART00000160800.1), the closest homolog to human 
CA5B, carbonic anhydrase Va (ca5a; NM_001111201.1), aarF domain 
containing kinase 4 (adck4; ENSDART00000172195.1), and phos-
phorylase kinase, alpha 2 (phka2; ENSDART00000078202.4).
Cilia staining in cells and zebrafish embryos. Fixed G0-synchronized 
cells were permeabilized with PBS containing 0.1% Triton X-100 and 
then blocked with 3% BSA in PBS containing 0.1 % Tween 20 (PBST). 
To visualize cilia in the KV, fixed zebrafish embryos of specific stages 
were processed according to Jaffe et al. (58). Primary antibodies spe-
cific for acetylated tubulin (1:500 in embryos, 1:1000 on cells, clone 
6-11b-1; Sigma-Aldrich), γTubulin (1:1000 in cells, T5192; Sigma- 
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or the AmpliCap SP6 High Yield Message Maker Kit (Cellscript). In 
preparation for in situ hybridization experiments, fragments of open 
reading frames of candidate genes identified in the heterotaxy exomes 
(see also “Whole-mount in situ hybridization”) were amplified using 
either GoTaq (Promega) or the Expand Long Range polymerase 
(Roche) and cloned into pCRII by TOPO TA cloning before lineariza-
tion and in vitro transcription of DIG-labeled antisense RNA using 
SP6 or T7 RNA polymerases (New England Biolabs).
Imaging. Confocal images were acquired on a TCS SP5II with 
LAS AF software (both Leica). Cells were analyzed using an AxioPhot 
(Zeiss), an ORCA-03G camera, and HoKaWo software (both Ham-
amatsu). Whole-mount embryos were imaged using a Leica M125 
equipped with a Leica IC80 HD camera. Movement trajectories of 
Tetrahymena thermophila were analyzed with a Discovery V8 equipped 
with an Axiocam 506 mono and ZEN software (all Zeiss).
Measurement of ciliary beat frequency (CBF) and KV flow. Embryos 
were mounted in 1% agarose and set under the ×100/1.30 NA oil 
immersion objective lens on a Nikon Eclipse Ti-U inverted microscope 
at room temperature (24°C–25°C). All images were taken with the dor-
sal roof of the KV facing the objective lens. Bright field images were 
recorded with a FASTCAM MC2 camera (Photron Europe Limited) con-
trolled with Photron FASTCAM Viewer software. Native particles were 
filmed at 60 frames per second (fps) for 30 seconds whereas cilia were 
recorded at 500 fps for 2 seconds. KV flow and CBF measurements 
were analyzed using Fiji software as previously described (23).
Analysis of Tetrahymena thermophila. The wild-type strain CU428 
(gift from Dorota Wloga, Nencki Institute, Warsaw, Poland) was main-
tained in SPP medium (1% proteose-peptone, 0.2% D+-glucose, 0.1% 
yeast extract, 0.03 g/l EDTA-Fe3+ salt; all from Sigma-Aldrich) in the 
dark and passaged every month. Exponentially growing cells at a den-
sity of 2 × 105 to 4 × 105 cells per ml were treated for 1 hour at 30°C 
with 40 rpm shaking with 50 μM DCHC, 180 μM rotenone, or DMSO 
as control, to manipulate mitochondrial function. To test phagocytosis 
efficiency, 100 μl cell suspension was supplemented with 10 μl draw-
ing ink 17 (Pelikan) and incubated without shaking for 10 minutes at 
30°C. Cells were then fixed with 4% PFA and vacuoles of at least 100 
cells from 5–6 independent experiments were counted using an Axio-
phot microscope (Zeiss). To measure swimming behavior, 1.2 ml of 
pretreated cells were transferred to a new 6-cm dish. In equal dark-
field settings for all treatments, cells were imaged with an exposure 
time of 10 seconds. Trajectories of over 400 cells from 2 indepen-
dent experiments were measured for each treatment with ImageJ.
Cryo-electron microscopy. Scanning transmission electron micro-
scopy (STEM) tomography was performed as previously described 
with some modifications (59). Sections (700-nm thick) were cut from 
the epoxy resin block parallel to the plane of the sapphire disc with an 
Ultracut UCT ultramicrotome (Leica) equipped with a diamond knife 
(Diatome). Before mounting the slice onto a special copper grid for 
tomography with parallel bars, the grid was plasma-cleaned with an 
Edwards plasma cleaning system. A droplet of 10% (wt/vol) poly-L- 
lysine (Sigma-Aldrich) in water was added on the sample and dried for 
5 minutes at 37°C. The grid with the slice on it was treated on both sides 
with 15 μl of a solution containing 25 nm gold particles (Aurion) diluted 
1:1 with water. Finally, the grid was coated on both sides with a 5 nm 
carbon layer using a BAF 300 electron beam evaporation device (Bal-
zers). Images were recorded in the STEM mode with a Jeol JEM-2100F 
(Jeol) with an acceleration voltage of 200 kV and a bright field detector 
a read depth of at least 10 were analyzed. A minor allele frequency 
(MAF) of less than 1% was used to further filter rare variants. Popu-
lation allele frequencies were obtained from the Database of Single 
Nucleotide Polymorphisms (dbSNP) build 147, the National Heart, 
Lung, and Blood Institute (NHLBI; ESP6500SI-V2-SSA137), and the 
Exome Aggregation Consortium (ExAC). A high priority list of 1174 
genes that localize to mitochondria or cause mitochondrial disorders 
was investigated (according to the Human MitoCarta2.0 [ref. 36] and 
the BCM-MitomeNGS [Baylor Genetics]). These were further prior-
itized by Combined Annotation Dependent Depletion (CADD) and 
dbNSFP Functional Prediction programs SIFT, Polyphen2 HVAR, 
MutationTaster, MutationAssessor, FATHMM, and FATHMM MKL 
Coding. For the variant burden analyses, we applied additional quality 
filters to the heterotaxy cohort and controls from the 1000 Genomes 
study. Variants in the heterotaxy cohort that passed a read depth of at 
least 10, genotype quality of at least 30, call rate of at least 0.8, and a 
cohort allele frequency no greater than 0.2 were used. For the 1000 
Genomes participants, the 1000 Genomes Pilot mask obtained from 
The International Genome Sample Resource (IGSR) was applied. Vari-
ants in both cohorts were further restricted to regions covered by the 
Nimblegen Seq capture platform. Missense variants with a MAF below 
0.1% in ExAC were filtered, followed by MetaSVM analysis to predict 
damaging and tolerated variants. We normalized damaging variants 
to tolerated variants to obtain the overall damaging variant burden 
ratio in mitochondria-associated genes and control gene lists. Control 
gene lists were created by identifying genes from external databases 
and clinical panels, including the Candidate Cancer Gene Database 
for cancer genes, Autism/ID Xpanded Panel from GeneDx for autism 
genes, and Orphanet, Online Mendelian Inheritance in Man (OMIM) 
Morbid, and The Developmental Disorders Genotype-Phenotype 
Database (DDG2P) for random disease genes (Supplemental Table 4). 
Control gene lists were matched to the mitochondria-associated gene 
list by total exon length (4,969,960 base pairs in mitochondria genes) 
with differences between the gene lists less than 1000 base pairs.
Verification of MO efficiency. MO efficiency was either verified by anti-
body staining (Phka2: rabbit anti-PHKA2, Proteintech, catalog no. 24658-
1-AP, lot 20988, 1:100; Osbpl1a: rabbit-anti-Osbpl1a, GeneTex, catalog 
no. GTX107722, clone C3, 1:200) or by RT-PCR to show splice blocking. 
Injection of the Mtrr splMO resulted in deletion of the start codon as ver-
ified with the following primers: 5′-GATTACCTGTTCCTCCCGTTC 
and 5′-ATGAGAAAGATGGTCGTGTGG. The Taz splMO interfered 
with regular splicing of exon 2, which was tested with the following prim-
ers: 5′-CGGAAGTGTGGTTTAATGCTG and 5′-TGATAAGGGGTGT-
GTCCTGAG. See complete unedited gels in the supplemental material.
Cloning and in vitro synthesis of RNA. Murine Ppargc1a (Pgc1a) 
(NM_008904.) was amplified from mouse cDNA generated from total 
RNA isolated out of lineage-negative hematopoietic progenitor cells 
and cloned via BamH/XhoI into pCS2+. A clone of human MTRR was 
purchased from Dharmacon (clone 40007734) and was subcloned by 
directional TOPO cloning into pcDNA3.1 before positional mutagen-
esis to induce the R552Q mutation as detected in heterotaxy patients. 
Similarly, the open reading frame of human TAZ (NM_000116) was 
amplified from cDNA of human fibroblasts, cloned via ClaI/StuI into 
pCS2+, and the R253Q mutation was introduced. For injection into 
zebrafish eggs, plasmids were linearized using NotI (pCS2+-mPgc1a) 
or PmeI (pcDNA3.1 constructs), respectively. Capped RNA was tran-
scribed using either the SP6 or T7 mMessage mMachine Kit (Ambion) 
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sequencing data for identification of mutations. MDB, MP, RJ, PS, 
SSL, PP, and HO analyzed data. PW performed electron microscopy 
experiments. MDB and MP wrote the manuscript.
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